The American Thoracic Society (ATS) Conference, 19 – 24 May 201
John Efthimiou, Executive Vice-President Translational Medicine R&D operations, will be making a poster presentation at the ATS 2017 conference in Washington, D.C. in May 2017.
This is one of the largest gatherings of researchers in the world. Each year, nearly 14,000 of these professionals attend and present sessions on allergy/immunology, behavioural science, cardiology, environmental and occupational health, infectious disease, pediatrics pulmonary, critical care, and sleep.
The Poster presentation (#P10477) titled “Differential White Blood Cell Changes During Human Rhinovirus (HRV) Induced Infection in Subjects with Asthma’” will take place throughout Monday 22nd May in session B31 Pre-Clinical and Translational Studies in Asthma.
Accompanying John Efthimiou at the event will Rich Niemi, Senior Director Business Development, and if you would like to contact either John before or during the event, please contact us here.